Dolutegravir for first-line antiretroviral therapy in low-income and middle-income countries: uncertainties and opportunities for implementation and research.
Loading...
Date
2018
Journal Title
Journal ISSN
Volume Title
Publisher
Elsevier.
Abstract
Abstract available in pdf.
Description
CAPRISA, 2018.
Keywords
HIV., Antiretroviral therapy., Dolutegravir., Viral load., Adherence., Resistance.
Citation
Dorward, J., Lessells, R., Drain, P.K., Naidoo, K., de Oliveira, T., Pillay, Y., Abdool Karim, S.S. and Garrett, N. 2018. Dolutegravir for first-line antiretroviral therapy in low-income and middle-income countries: uncertainties and opportunities for implementation and research. Lancet HIV 5(7), e400-e404.